Privia Health $525.8 million IPO
We advised Privia Health on its IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
EnVen Energy $300 million high-yield notes offering and credit facility amendment
We advised EnVen on its senior secured notes offering and credit facility
Century Aluminum $86.25 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A offering
Mastercard $1.3 billion notes offering, with its first sustainability bonds
We advised Mastercard on its inaugural sustainability bond offering
Taboola $2.6 billion merger with ION Acquisition Corp. 1
We are advising Taboola on its merger with a SPAC
Veritiv secondary offering
Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,400,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common…
LendingTree $872 million secondary offering
Davis Polk advised LendingTree, Inc. in connection with the $872 million secondary offering of 2,955,984 shares of its common stock by Ventures Holdco II, LLC, which is a wholly owned…
Mission Produce $96 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $96 million initial public offering by Mission Produce, Inc. of 8,000,000 shares of its…
Biondvax Pharmaceuticals $100 million at-the-market offering
Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …
American Well $853 million IPO and NYSE listing
Davis Polk advised American Well Corporation (“Amwell”) in connection with its initial public offering of 47,405,555 shares of Class A common stock for approximately $853 million in total…